Aptorum Group: Aptorum is Hong Kong based, US listed company (Mcap $100m) focused on generating late stage clinical candidates by developing already approved drugs for new orphan indications, as well as infectious diseases.

Pipeline –
• SACT-1 for Neuroblastoma – ph2/3 trial planned for 2H’20
• SACT-COV19 – COVID-19 treatment - preclinical
Based in...
Public, USA
Market Cap
100MM - 500MM
17/F, Guangdong Investment Tower
148 Connaught Road
Hong Kong, Hong Kong Island 999077
Hong Kong

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Aptorum Group Limited Class A

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Renaissance Technologies LLC 0.50 33,035 0.11 13F 2020-03-31
Morgan Stanley Capital Services LLC 0.07 4,665 0.02 13F 2020-03-31
Geode Capital Management LLC 0.01 470 0.00 Funds 2020-05-31
UBS Group AG (13f Subfiler) 0.00 172 0.00 13F 2020-03-31
Deutsche Bank AG (13F Subfiler) 0.00 0 0.00 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.